Below are the top biotechnology stocks on the NYSE in terms of return on assets. The trailing-twelve-month return on assets at Charles River Laboratories International (NYSE: CRL ) is 7.63%. Charles River Laboratories' operating margin for the same period is 16.89%. The trailing-twelve-month return on assets at Emergent BioSolutions (NYSE: